Market Overview

Tesaro Comes Roaring Back From Much Lower Open

Related TSRO
Tesaro Sheds $20 Over The Last Three Days
A Biotech Binary Event Playbook: How To Play Clovis And Tesaro Ahead Of Label Decision
Related CLVS
Wall Street's M&A Chatter From September 18: Walgreens-Rite Aid, Northrup Grumman-Orbital ATK, Itron-Silver Spring Networks
Clovis Oncology Higher Off Unconfirmed Takeover Chatter

TESARO Inc (NASDAQ: TSRO) shares are trading lower by $2.31 at $142 in Monday's session. The catalyst for the much lower open was the announcement that rival Clovis Oncology Inc (NASDAQ: CLVS) reported positive results for its cancer, which is in direct competition with a treatment Tesaro has in the pipeline.

After a much lower open, it continued in that direction before bottoming in the first minute of the session at $129.04 and embarked on a vicious rebound. So far, the ensuing rally has taken the issue beyond the lower-end of Friday's range ($142.63) as $143.30 stands as the current high of the day. If the rally continues beyond that high, there may be additional resistance at the pair of closes from Thursday ($144.23) and Friday ($144.31).

Posted-In: Biotech News Technicals Intraday Update Movers Trading Ideas General


Related Articles (CLVS + TSRO)

View Comments and Join the Discussion!